1. Yurko-Mauro K, McCarthy D, Rom D, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement
2. J.V. Pottala, K. Yaffe, J.G. Robinson, M.A. Espeland, R. Wallace, W.S. Harris. Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI Study. Neurology, 82 (2014), pp. 435-442
3. Rail C, Erickson K, Lopez O et al. Regular Fish Consumption and Age-Related Brain Gray Matter Loss. American Journal of Preventive Medicine. 2014.
4. Urban Kimberly R., Gao Wen-Jun. Performance Enhancement at the Cost of Potential Brain Plasticity: Neural Ramifications of Nootropic Drugs in the Healthy Developing Brain. Frontiers in Systems Neuroscience. 2014.
5. Titova O, et al. “Dietary intake of eicosapentaenoic and docosahexaenoic acid is linked to gray matter volume and cognitive function in elderly.” Age. 2013;35(4):1495-1505.
6. Rail C, Erickson K, Lopez O et al. Regular Fish Consumption and Age-Related Brain Gray Matter Loss.
American Journal of Preventive Medicine. 2014.
7. Bredesen DE. Reversal of cognitive decline: A novel therapeutic program. Aging. 2014.
8. Cao D, Kevala K, Kim J, Moon H, Jun S, Lovinger D, Kim H. “Docosahexaenoic acid promotes hippocampal
neuronal development and synaptic function.” J Neurochem. 2009;111(2):510-21.
9. Katakura M, Hashimoto M, Md Shahdat H, Gamoh S, Okui T, Matsuzaki K, Shido O. Docosahexaenoic acid promotes neuronal differentiation by regulating basic helix-loop-helix transcription factors and cell cycle in neural stem cells. Neuroscience. 2009 March
10. Freund-Levi Y, Palmblad J, Vedin I, et al. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid (DHA)-rich omega-3 fatty acid preparation in patients with Alzheimer’s disease: the OmegAD study. Journal of Internal Medicine. 2013.
11. Bazan N, Musto A, Knott E. “Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity.” Mol Neurobiol. 2011;44(2):216-22.
12. J.V. Pottala, K. Yaffe, J.G. Robinson, M.A. Espeland, R. Wallace, W.S. Harris. Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI Study. Neurology, 82 (2014), pp. 435-442
13. Heras-Sandoval D, Pedraza-Chaverri J, Pérez-Rojas JM. Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer’s disease. J Neuroinflammation. 2016 Mar 10;13(1):61.
14. Kim HY, et al. N-Docosahexaenoylethanolamide promotes development of hippocampal neurons. Biochem J. 2011 Apr 15;435(2):327-36.
15. . Lukiw WJ, Cui J-G, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 2005
17. Brenna JT, Carlson SE. Docosahexaenoic acid and human brain development: Evidence that a dietary supply is needed for optimal development. J. Hum. Evol. 2014; Apr 26.
18. Tan Z, Harris W, Beiser A, Au R, Himali J, Debette S, Pikula A, Decarli C, Wolf P, Vasan R, Robins S, Seshadri S. “Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging.” Neurology. 2012;78(9):658-64.
19. Richardson AJ, Burton JR, Sewell RP, Spreckelsen TF, Montgomery P (2012) Docosahexaenoic Acid for Reading, Cognition and Behavior in Children Aged 7-9 Years: A Randomized, Controlled Trial (The DOLAB Study). . PLoS ONE 7(9): e43909
20. Tso et. al. “Method of Retarding and Ameliorating Central Nervous System and Eye… ” U.S. Patent: #US5527533, Assignee: Board of Trustees of the University of Illinois, Urbana, IL
21. Zhu H, et al. “Increased telomerase activity and vitamin D supplementation in overweight African Americans.” Int J Obes. 2013;36(6):
22. Punder K, et al. “Stress and immunosenescence: the role of telomerase.” Psychoneurodocrinology. 2019;101:87-100
23. Makpol S, et al. “γ-Tocotrienol prevents oxidative stress-induced telomere shortening in human fibroblasts derived from different aged individuals.” Oxid Med Cell Longev. 2010;3(1):35-43.
24. Simes D, et al. “Vitamin K as a diet supplement with impact in human health: Current evidence in age-related diseases.” Nutrients. 2020;12(1):138.
26. Farzaneh-Far R, Lin J, Epel E, Lapham K, Blackburn E, Whooley MA (2010) Telomere Length Trajectory
and Its Determinants in Persons with Coronary Artery Disease: Longitudinal Findings from the Heart and
Soul Study. PLoS ONE 5(1): e8612
27. Farzaneh-Far R, et al. “Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease.” JAMA. 2010;303(3):250.
28. Kevin C Maki, Mathew S Reeves, Mildred Farmer, Mikko Griinari, Kjetil Berge, Hogne Vik, Rachel Hubacher, Tia M Rains. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res. 2009 Sep;29(9):609-15.
29.“Is Krill Oil 48X Better than Fish Oil.” Omegavia.com. September 25, 2011.